Enveric Biosciences

Funding and NIH signals

• SEC Form D raise Raised $5M (Form D filed May 4, 2026); +2 other Form D filings in the last 12 months. SEC Form D 0000890821-26-000002 (May 4, 2026)
  Evidence (3 events)

  • May 4, 2026 · SEC Form D 0000890821-26-000002
    Name of Issuer: Enveric Biosciences, Inc.; CIK: 890821; Address: Cambridge, MA; Submission type: D; Filing date: 2026-05-04; Industry Group: Biotechnology; Date of First Sale: 2026-04-17; Types of Securities Offered: Equity, Option/warrant; Business combination transaction: false; Total Offering Amount: 5000002; Total Amount Sold: 5000002; Federal exemptions: 06b
  • Feb 11, 2026 · SEC Form D 0000890821-26-000001
    Name of Issuer: Enveric Biosciences, Inc.; CIK: 890821; Address: Cambridge, MA; Submission type: D; Filing date: 2026-02-11; Industry Group: Biotechnology; Date of First Sale: 2026-01-28; Types of Securities Offered: Option/warrant; Business combination transaction: false; Total Offering Amount: 1450017; Total Amount Sold: 1450017; Federal exemptions: 06b
  • Dec 23, 2025 · SEC Form D 0000890821-25-000006
    Name of Issuer: Enveric Biosciences, Inc.; CIK: 890821; Address: Cambridge, MA; Submission type: D; Filing date: 2025-12-23; Industry Group: Biotechnology; Date of First Sale: 2025-12-12; Types of Securities Offered: Option/warrant; Business combination transaction: false; Total Offering Amount: 106598; Total Amount Sold: 106598; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals